Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02484417
What this trial is testing

Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers

Who this might be right for
Upper Respiratory Tract Infection
National Institute of Allergy and Infectious Diseases (NIAID) 32
Large-scale testing (Phase 3)Study completedNCT06042049
What this trial is testing

Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab

Who this might be right for
Respiratory Syncytial Virus Infections
AstraZeneca 33
Large-scale testing (Phase 3)Looking for participantsNCT07768345
What this trial is testing

Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)
Pfizer 440
Testing effectiveness (Phase 2)Study completedNCT03334695
What this trial is testing

An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 64
Testing effectiveness (Phase 2)Study completedNCT02979431
What this trial is testing

Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection

Who this might be right for
Respiratory Syncytial Virus Lower Respiratory Tract Infection
Ablynx, a Sanofi company 180
Not applicableUnknownNCT03627572
What this trial is testing

RESCEU Study: Defining the Burden of Disease of Respiratory Syncytial Virus in Europe in Infants

Who this might be right for
RSV InfectionRespiratory Syncytial Virus InfectionsRSV Bronchiolitis
UMC Utrecht 10,000
Not applicableStudy completedNCT04415229
What this trial is testing

RSV Seasonality in Martinique in Children Aged 2 Years or Less

Who this might be right for
Bronchiolitis; Respiratory Syncytial Virus
University Hospital Center of Martinique 1,237
Post-approval studies (Phase 4)Study completedNCT00001903
What this trial is testing

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)Study completedNCT06481579
What this trial is testing

IVX-A12 in Adults Participants

Who this might be right for
Healthy Participants
Icosavax, Inc. 143
Early research (Phase 1)Study completedNCT00504907
What this trial is testing

Safety Study of Oral BTA9881 to Treat RSV Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Biota Scientific Management Pty Ltd 63
Large-scale testing (Phase 3)Study completedNCT05879107
What this trial is testing

Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,113
Testing effectiveness (Phase 2)Ended earlyNCT04978337
What this trial is testing

Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus
Janssen Research & Development, LLC 5
Not applicableStudy completedNCT01563692
What this trial is testing

Immune Response to Respiratory Syncytial Virus (RSV) in Health Care Workers

Who this might be right for
Healthy
University of Oxford 30
Early research (Phase 1)Study completedNCT06604767
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionMetapneumovirus InfectionParainfluenzae Virus Infection
Sanofi Pasteur, a Sanofi Company 390
Post-approval studies (Phase 4)Study completedNCT06551506
What this trial is testing

The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 181
Early research (Phase 1)Not Yet RecruitingNCT07492706
What this trial is testing

Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women

Who this might be right for
Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company 120
Early research (Phase 1)Study completedNCT01459198
What this trial is testing

Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableUnknownNCT05348616
What this trial is testing

Impact of the Covid-19 on RSV

Who this might be right for
RhinovirusRSV Infection
Hospices Civils de Lyon 600
Early research (Phase 1)Active Not RecruitingNCT06442241
What this trial is testing

A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)RSV Infection
Guangzhou Patronus Biotech Co., Ltd. 84
Large-scale testing (Phase 3)Looking for participantsNCT07402512
What this trial is testing

A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children

Who this might be right for
Respiratory Syncytial Virus Infection
Simcere Pharmaceutical Co., Ltd 498
Next Page